Article
Genome-Wide CRISPR Screening Identifies BRD9 as a Druggable Component of…
medRxiv · 2021 · Börold, J.; Eletto, D.; Busnadiego, I.; Mair, N. K.; Moritz, E.; Schiefer, S.; Schmidt, N.; Petric, P. P.; Wong, W. W.-L.; Schwemmle, M.; Hale, B. G.
Key facts
| Title | Genome-Wide CRISPR Screening Identifies BRD9 as a Druggable Component of Interferon-Stimulated Gene Expression and Antiviral Activity |
|---|---|
| First author | Börold, J.; Eletto, D.; Busnadiego, I.; Mair, N. K.; Moritz, E.; Schiefer, S.; Schmidt, N.; Petric, P. P.; Wong, W. W.-L.; Schwemmle, M.; Hale, B. G. |
| Journal | medRxiv |
| Published | Feb 4, 2021 |
| DOI | 10.1101/2021.02.04.429732 |
| Devices mentioned | BK110039, DEN000008, K022086, K103302 |
| Product codes mentioned | JCI, KIP, KIT, NDS, NJT, OOI, PFT, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1